Single-cell Omics Market Size & Growth Forecast 2027–2036, By Segments (Product Type Scope, Application Scope, End-User Scope), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Single-cell Omics Market size stood at USD 2.6 billion in 2026 and is predicted to grow at a 15.3% CAGR from 2027 to 2036, crossing USD 10.8 billion by 2036. The industry revenue for 2027 is assessed at USD 2.93 billion.
Get more details on this report
Request Free Sample ReportSingle-cell Omics Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 49.15% of the market in 2026, supported by advanced genomics research infrastructure, strong biotechnology activity, and widespread integration of high-throughput analytical workflows.
- Asia Pacific is projected to expand at a 17.92% CAGR as investment in genomics, laboratory capacity, and biotechnology research strengthens adoption of advanced single-cell analysis.
Segment Momentum
- Single-cell genomics accounted for 48.55% of the market in 2026 because it is widely used to study cellular heterogeneity, mutations, lineage relationships, and disease-related molecular patterns.
- Immunology is growing fastest because researchers increasingly require single-cell analysis to understand immune cell diversity, activation states, and functional interactions beyond the capabilities of bulk methods.
Market Expansion Drivers
- Rapid advancements in single-cell sequencing technologies enhancing resolution and analytical capabilities.
- Expanding oncology research and precision medicine demand accelerating single-cell analysis adoption.
- Increasing multi-omics integration and biopharmaceutical R&D funding driving platform innovation.
Leading Market Participants
- Prominent players in the single-cell omics market include 10x Genomics, Inc. (United States), Illumina, Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Becton, Dickinson and Company (United States), Standard BioTools Inc. (United States), Mission Bio, Inc. (United States), CYTENA GmbH (Germany), Cellenion GmbH (Germany), Revvity, Inc. (United States), ANGLE plc (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.6 billion
- 2027 Estimated Market Size: USD 2.93 billion.
- Projected Market Size: USD 10.8 billion by 2036
- Growth Forecast: 15.3% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Single-Cell Genomics (Product Type Scope) | Oncology (Application Scope) | Academic and Research Organizations (End-User Scope)
- Emerging Opportunity Segment: Single-Cell Metabolomics (Product Type Scope) | Immunology (Application Scope) | Pharmaceutical & Biotechnology Companies (End-User Scope)
Market Growth Drivers and Industry Trends
Rapid advancements in single-cell sequencing technologies enhancing resolution and analytical capabilities
Technological improvements in sequencing will drive the single-cell omics market growth by enabling researchers to examine biological characteristics at increasingly detailed cellular resolution. Enhanced analytical capabilities allow studies to distinguish cellular differences more effectively, supporting broader use of single-cell approaches in research and translational applications.
Expanding oncology research and precision medicine demand accelerating single-cell analysis adoption
Growing interest in cancer research and precision medicine will propel the single-cell omics market growth as researchers require more detailed understanding of cellular heterogeneity and disease mechanisms. Single-cell analysis enables investigation of distinct cell populations, supporting research approaches that seek more targeted biological insights and treatment strategies.
Increasing multi-omics integration and biopharmaceutical R&D funding driving platform innovation
Greater integration of multiple molecular datasets will strengthen the single-cell omics market growth by expanding the analytical depth available to researchers and biopharmaceutical development teams. Rising R&D investment also supports development of more capable platforms that combine single-cell measurements with broader biological information for drug discovery and research applications.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing single-cell research in genomics | 4.50% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Fast |
| Advancements in sequencing and omics technologies | 4.00% | Medium term (2–5 yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Moderate |
| Expansion of personalized medicine applications | 3.50% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Slow |
| Rapid advancements in single-cell sequencing technologies enhancing resolution and analytical capabilities | 3.40% | Moderate | North America, Europe | High | Near Term |
| Expanding oncology research and precision medicine demand accelerating single-cell analysis adoption | 3.20% | High | North America, Asia Pacific | High | Near Term |
| Increasing multi-omics integration and biopharmaceutical R&D funding driving platform innovation | 3.00% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The single-cell omics market was dominated by North America, which captured a 49.15% share in 2026, owing to strong biomedical research capabilities, advanced genomics infrastructure, and extensive adoption of high-resolution molecular analysis technologies. The region benefits from substantial research activity in oncology, immunology, neuroscience, and other complex disease areas where characterization of individual cells can provide deeper biological insights. Well-developed sequencing and bioinformatics capabilities, sophisticated research institutions, and increasing integration of multi-omics approaches are supporting demand for single-cell technologies. Growing emphasis on precision medicine and translational research is also encouraging researchers to use single-cell approaches for identifying cellular heterogeneity and disease mechanisms.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, supported by expanding biotechnology research, increasing investment in genomics infrastructure, and broader adoption of advanced molecular analysis technologies. Rising research activity in cancer biology, infectious diseases, immunology, and personalized medicine is creating new applications for single-cell sequencing and related analytical platforms. Improvements in laboratory capabilities and growing collaboration between research institutions and healthcare organizations are also helping expand access to these technologies. As regional biomedical research increasingly focuses on cellular-level disease characterization, the demand for scalable and sophisticated single-cell omics workflows is gaining momentum.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Biology ResearchGermany focuses on integrating single-cell omics into biomedical research programs investigating disease mechanisms and therapeutic development. Research institutions in Germany continue expanding advanced sequencing and bioinformatics capabilities for comprehensive cellular profiling.
France 🇫🇷
Clinical Research IntegrationFrance strengthens single-cell omics adoption across clinical and translational research programs focused on oncology and immune disorders. French research centers continue integrating advanced sequencing platforms with collaborative biomedical research initiatives.
Italy 🇮🇹
Academic Genomics ExpansionItaly advances single-cell omics through university research and collaborative biomedical projects emphasizing disease characterization. Italian researchers increasingly adopt high-resolution cellular analysis to support molecular diagnostics and therapeutic research.
Japan 🇯🇵
Regenerative Medicine SupportJapan applies single-cell omics extensively in regenerative medicine and stem cell research to better understand cellular function. Japanese laboratories continue strengthening analytical workflows that support translational research and personalized therapeutic strategies.
South Korea 🇰🇷
Genomics Innovation HubSouth Korea expands single-cell omics capabilities through investments in genomics infrastructure and advanced life science research. Research organizations in South Korea increasingly combine multi-omics technologies with computational analysis for improved biological insights.
United States 🇺🇸
Translational Research PlatformThe U.S. advances single-cell omics through strong collaboration among academic institutions, biotechnology companies, and healthcare organizations. Researchers in the U.S. prioritize high-resolution cellular analysis to accelerate biomarker discovery and precision medicine development.
Segment Leadership and Growth Trends
Single-cell Omics Market Share (%), by Product Type Scope, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Scope Segment Analysis: Single-Cell Genomics (Largest Segment) vs Single-Cell Metabolomics (Fastest-Growing Segment)
Single-cell genomics led the single-cell omics market with a 48.55% share in 2026, supported by its ability to characterize genetic variation and cellular heterogeneity at the individual-cell level. Researchers increasingly rely on genomic profiling to investigate disease mechanisms, identify distinct cell populations, and improve understanding of complex biological systems. Its broad relevance across biomedical research and translational applications continues to reinforce demand for single-cell genomic technologies.
Single-cell metabolomics is expected to register the fastest growth as researchers increasingly seek deeper insight into cellular metabolism and the biochemical processes underlying disease and biological function. Metabolomic profiling at the single-cell level can reveal metabolic differences that may remain hidden in population-level analyses, supporting more detailed characterization of cellular states. Growing interest in comprehensive multi-omics research is further encouraging the adoption of metabolomics alongside established genomic approaches.
Application Scope Segment Analysis: Oncology (Largest Segment) vs Immunology (Fastest-Growing Segment)
Oncology accounted for 57.86% of the single-cell omics market in 2026, reflecting the importance of high-resolution cellular analysis in understanding tumor heterogeneity, disease progression, and treatment response. Single-cell technologies enable researchers to distinguish diverse cell populations within tumors and investigate interactions between malignant and surrounding cells. The increasing emphasis on precision medicine and detailed molecular characterization is strengthening the use of single-cell omics across cancer research and therapeutic development.
Immunology is anticipated to experience the fastest growth as researchers increasingly apply single-cell approaches to characterize immune-cell diversity, activation states, and cellular interactions. Detailed profiling can improve understanding of immune responses and support investigation of complex immune-mediated diseases and therapeutic mechanisms. Growing interest in immune profiling and the development of more precise biological insights is creating strong opportunities for single-cell omics within immunology.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type Scope | Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics | Single-Cell Genomics | Single-Cell Metabolomics |
| Application Scope | Oncology, Cell Biology, Neurology, Immunology | Oncology | Immunology |
| End-User Scope | Pharmaceutical & Biotechnology Companies, Academic and Research Organizations, Hospital and Diagnostic Laboratories, Others | Academic and Research Organizations | Pharmaceutical & Biotechnology Companies |
Competitive Landscape and Market Positioning
Leading companies in the single-cell omics market:
1. 10x Genomics Inc. (United States)
2. Illumina Inc. (United States)
3. Bio-Rad Laboratories Inc. (United States)
4. Becton Dickinson and Company (United States)
5. Standard BioTools Inc. (United States)
6. Mission Bio Inc. (United States)
7. CYTENA GmbH (Germany)
8. Cellenion GmbH (Germany)
9. Revvity Inc. (United States)
10. ANGLE plc (United Kingdom)
The single-cell omics market is increasingly shaped by cross-disciplinary collaboration and rapid technological integration. Advances in high-resolution analytical platforms are enabling deeper cellular profiling, while continuous R&D efforts are expanding application scope in precision biology. The single-cell omics market is also seeing frequent introduction of upgraded tools that improve throughput and data accuracy. Overall momentum is driven by convergence of bioinformatics and experimental innovation.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| 10x Genomics Inc. (United States) | |||||||
| Illumina Inc. (United States) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Standard BioTools Inc. (United States) | |||||||
| Mission Bio Inc. (United States) | |||||||
| CYTENA GmbH (Germany) | |||||||
| Cellenion GmbH (Germany) | |||||||
| Revvity Inc. (United States) | |||||||
| ANGLE plc (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Illumina | Feb-26 | Illumina established strategic partnerships with SPT Labtech and Takara Bio to integrate automated sample preparation and spatial transcriptomics into single-cell workflows. This collaboration focuses on scaling high-throughput analysis and enhancing genomic disease characterization, directly impacting the operational efficiency and technological standardization of multi-omics research and spatial biology applications. |
| SONRAI BioDiscovery | Nov-25 | SONRAI BioDiscovery launched an integrated analytical platform designed to unify multimodal biological datasets for advanced tertiary analysis. By creating a cohesive framework to synthesize complex multi-omics layers, the solution improves the interpretability of single-cell data, supporting more robust biological insights and accelerating data-driven discovery in complex omics environments. |
| Takara Bio USA | Oct-25 | Takara Bio USA expanded its spatial biology portfolio to bridge the gap between single-cell and spatial research. This strategic portfolio update aims to broaden researcher access to integrated analysis tools, enhancing the capability to combine spatial context with single-cell data to achieve a more comprehensive understanding of biological systems. |
| SEISMIC | Jul-24 | SEISMIC accelerated R&D initiatives in single-cell multi-omics, specifically targeting oncological applications. The company’s efforts focus on leveraging multi-omics technologies to better characterize tumor heterogeneity and cancer progression, providing critical advancements for precision oncology workflows and the development of sophisticated disease models. |
| BD | Feb-23 | BD introduced a high-throughput single-cell multi-omics analysis platform designed to maintain sample integrity. This technology deployment serves to increase operational scalability for large-scale studies, representing a significant enhancement in the capabilities available to researchers for deep-phenotyping and discovery across diverse biological fields. |
| SCIENION | Jun-21 | SCIENION and Cellenion launched the cellenCHIP 384 platform alongside a specialized 3'RNA-seq kit for nanoliter-volume single-cell library preparation. This development significantly improves the scalability and precision of sample preparation workflows, offering a standardized, high-throughput solution for single-cell genomics research and supporting more efficient large-scale laboratory processes. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Single-cell Omics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Workflow Stage | Sample Preparation and Cell Isolation, Library Preparation, Sequencing and Analysis, Data Interpretation |
| Sample Type | Blood and Immune Cells, Solid Tissue, Stem and Progenitor Cells, Cultured Cells |
| Throughput | Low Throughput, Medium Throughput, High Throughput, Ultra-High Throughput |
Single-cell Omics Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Precision Medicine Adoption Landscape |
|
| Pharmaceutical Discovery Application Opportunities |
|
| Data Ecosystem and Bioinformatics Strategy |
|
Need a different cut of the data?
Request Custom ResearchHow large is the single-cell omics market?
How is the single-cell omics industry expected to grow over the next 10 years?
Why is multi-omics integration becoming a key driver of platform development in the single-cell omics market?
How is expanding oncology research influencing adoption of single-cell omics technologies?
Why does single-cell genomics lead the single-cell omics market?
Why is immunology the fastest-growing application in the single-cell omics market?
Why does North America lead the single-cell omics market?
Why is Asia Pacific the fastest-growing region in the single-cell omics market?
Who holds a significant market share in the single-cell omics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization